JAMA Netw Open 3:e207419 Paccou J et al (2022) Bariatric surgery and skeletal health: a narrative review and position statement for management by the European calcified tissue society (ECTS)
Di GiuseppeR.BertuzziTRossiFRastelliSMulazziACapraroJet al
Although NAION is rare, available data shows that individuals using GLP-1 medications appear to be more likely to experience optic nerve stroke than the general population
The effect of different agents on HbA1c and body weight in the various studies reported here are summarised in Table 1
The "supplement GLP-1" versus real GLP-1 gap Jamie Alan, Associate Professor of Pharmacology and Toxicology at Michigan State University, put it simply: "If you can buy it without a prescription, it is not an actual GLP-1 drug." This distinction matters enormously
Patients receiving semaglutide 2.4 mg in this trial lost 9.9% of their body weight, compared with 0.4% in those receiving placebo [33]